Pregled bibliografske jedinice broj: 489307
Reversal of Multidrug Resistance in Murine Lymphoma Cells by Amphiphilic Dihydropyridine Antioxidant Derivative
Reversal of Multidrug Resistance in Murine Lymphoma Cells by Amphiphilic Dihydropyridine Antioxidant Derivative // Anticancer research, 30 (2010), 10; 4063-4070 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 489307 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Reversal of Multidrug Resistance in Murine Lymphoma Cells by Amphiphilic Dihydropyridine Antioxidant Derivative
Autori
Cindrić, Marina ; Čipak, Ana ; Serly, Julianna ; Plotniece, Aiva ; Jaganjac, Morana ; Mrakovčić, Lidija ; Lovaković, Tomislava ; Dedić, Azra ; Soldo, Ivo ; Duburs, Gunars ; Žarković, Neven ; Molnár, József
Izvornik
Anticancer research (0250-7005) 30
(2010), 10;
4063-4070
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
cancer ; doxorubicin ; MDR reversal ; dihydropyridine derivative ; oxidative stress ; antioxidant
Sažetak
Multidrug resistance, the principal mechanism by which cancer cells develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapies. The aim of the study was to investigate the effect of K-2-11 on the reversal of multidrug resistance. The effects of amphiphilic dihydropyridine derivative K-2-11 were tested on MDR1-expressing mouse lymphoma cells and their parental control. The effects of K-2-11 with and without doxorubicin were studied by determination of cell viability, cell proliferation and production of reactive oxygen species. K-2-11 caused complete reversal of multidrug resistance of the MDR cells, being much more efficient than the positive control verapamil. Accordingly, the cytotoxic effects of doxorubicin were enhanced by K-2-11, both in the MDR and in parental cell line, while K-2-11 alone did not affect cell viability. K-2-11 also acted as an antioxidant, reducing the cellular generation of reactive oxygen species. Our results indicate the high potential of K-2-11 as a novel antioxidant with potent MDR-blocking ability that should be studied further for development in adjuvant anticancer treatments.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982464-2519 - Lipidi, slobodni radikali i njihovi glasnici u integrativnoj onkologiji (Žarković, Neven, MZOS ) ( CroRIS)
108-0000000-0028 - Oksidacijski stres i tumori središnjeg živčanog sustava (Žarković, Kamelija, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb
Profili:
Ana Čipak Gašparović
(autor)
Lidija Milković
(autor)
Neven Žarković
(autor)
Marina Cindrić
(autor)
Morana Jaganjac
(autor)
Tomislava Lovaković
(autor)
Ivo Soldo
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE